Literature DB >> 23876304

Isolation and characterization of canine natural killer cells.

Helen T Michael1, Daisuke Ito, Valarie McCullar, Bin Zhang, Jeffrey S Miller, Jaime F Modiano.   

Abstract

NK cells are non-T, non-B lymphocytes that kill target cells without previous activation. The immunophenotype and function of these cells in humans and mice are well defined, but canine NK cells remain incompletely characterized. Our objectives were to isolate and culture canine peripheral blood NK cells, and to define their immunophenotype and killing capability. PBMC were obtained from healthy dogs and T cells were depleted by immunomagnetic separation. The residual cells were cultured in media supplemented with IL-2, IL-15 or both, or with mouse embryonic liver (EL) feeder cells. Non-T, non-B lymphocytes survived and expanded in these cultures. IL-2 was necessary and sufficient for survival; the addition of IL-15 was necessary for expansion, but IL-15 alone did not support survival. Culture with EL cells and IL-2 also fostered survival and expansion. The non-T, non-B lymphocytes uniformly expressed CD45, MHC I, and showed significant cytotoxic activity against CTAC targets. Expression of MHC II, CD11/18 was restricted to subsets of these cells. The data show that cells meeting the criteria for NK cells in other species, i.e., non-T, non-B lymphocytes with cytotoxic activity, can be expanded from canine PBMC by T-cell depletion and culture with cytokines or feeder cells. Published by Elsevier B.V.

Entities:  

Keywords:  Canine; Interleukins; NK cells

Mesh:

Substances:

Year:  2013        PMID: 23876304      PMCID: PMC4019669          DOI: 10.1016/j.vetimm.2013.06.013

Source DB:  PubMed          Journal:  Vet Immunol Immunopathol        ISSN: 0165-2427            Impact factor:   2.046


  46 in total

1.  Cross-reactive anti-human monoclonal antibodies as a tool for B-cell identification in dogs and pigs.

Authors:  M Faldyna; P Samankova; L Leva; J Cerny; J Oujezdska; Z Rehakova; J Sinkora
Journal:  Vet Immunol Immunopathol       Date:  2007-06-26       Impact factor: 2.046

Review 2.  Uterine natural killer cells: a specialized differentiation regulated by ovarian hormones.

Authors:  B Anne Croy; Marianne J van den Heuvel; Angela M Borzychowski; Chandrakant Tayade
Journal:  Immunol Rev       Date:  2006-12       Impact factor: 12.988

3.  Survival advantage with KIR ligand incompatibility in hematopoietic stem cell transplantation from unrelated donors.

Authors:  Sebastian Giebel; Franco Locatelli; Teresa Lamparelli; Andrea Velardi; Stella Davies; Guido Frumento; Rita Maccario; Federico Bonetti; Jerzy Wojnar; Miryam Martinetti; Francesco Frassoni; Giovanna Giorgiani; Andrea Bacigalupo; Jerzy Holowiecki
Journal:  Blood       Date:  2003-04-10       Impact factor: 22.113

4.  An immunophenotypic study of canine leukemias and preliminary assessment of clonality by polymerase chain reaction.

Authors:  W Vernau; P F Moore
Journal:  Vet Immunol Immunopathol       Date:  1999-08-02       Impact factor: 2.046

5.  Age-associated changes in the immune system of German shepherd dogs.

Authors:  A Strasser; A Teltscher; B May; C Sanders; H Niedermüller
Journal:  J Vet Med A Physiol Pathol Clin Med       Date:  2000-04

6.  Influence of different tumour types on natural cytotoxicity (NK cell activity) and mitogen-induced lymphocyte proliferation in isolated blood lymphocytes from 110 dogs with tumours.

Authors:  J Funk; G Schmitz; U Bach; K Failing; E Burkhardt
Journal:  Res Vet Sci       Date:  2003-04       Impact factor: 2.534

7.  Natural killer (NK) and lymphokine-activated killer (LAK) cell functions from healthy dogs and 29 dogs with a variety of spontaneous neoplasms.

Authors:  Jürgen Funk; Gabriele Schmitz; Klaus Failing; Eberhard Burkhardt
Journal:  Cancer Immunol Immunother       Date:  2005-01       Impact factor: 6.968

8.  Mouse fetal and embryonic liver cells differentiate human umbilical cord blood progenitors into CD56-negative natural killer cell precursors in the absence of interleukin-15.

Authors:  Valarie McCullar; Robert Oostendorp; Angela Panoskaltsis-Mortari; Gong Yun; Charles T Lutz; John E Wagner; Jeffrey S Miller
Journal:  Exp Hematol       Date:  2008-03-04       Impact factor: 3.084

9.  Differential regulation of GM1 and asialo-GM1 expression by T cells and natural killer (NK) cells in respiratory syncytial virus infection.

Authors:  Martin L Moore; Michael H Chi; Kasia Goleniewska; Joan E Durbin; R Stokes Peebles
Journal:  Viral Immunol       Date:  2008-09       Impact factor: 2.257

10.  CD5-low expression lymphocytes in canine peripheral blood show characteristics of natural killer cells.

Authors:  Yi-Chun Huang; Shao-Wen Hung; Tong-Rong Jan; Kuang-Wen Liao; Chiung-Hsiang Cheng; Yu-Shan Wang; Rea-Min Chu
Journal:  J Leukoc Biol       Date:  2008-08-15       Impact factor: 4.962

View more
  14 in total

Review 1.  Targeting Cancer Stem Cells with Natural Killer Cell Immunotherapy.

Authors:  Jesus I Luna; Steven K Grossenbacher; William J Murphy; Robert J Canter
Journal:  Expert Opin Biol Ther       Date:  2016-12-23       Impact factor: 4.388

2.  Activating natural killer (NK) cytotoxicity of canine CD5-CD21- cells requires low surface CD5 density NK cells.

Authors:  C S Lin; C P Chang; H C Chiang; T F Chuang; C H Hsu; C C Liu
Journal:  Iran J Vet Res       Date:  2018       Impact factor: 1.376

Review 3.  Canine cancer immunotherapy studies: linking mouse and human.

Authors:  Jiwon S Park; Sita S Withers; Jaime F Modiano; Michael S Kent; Mingyi Chen; Jesus I Luna; William T N Culp; Ellen E Sparger; Robert B Rebhun; Arta M Monjazeb; William J Murphy; Robert J Canter
Journal:  J Immunother Cancer       Date:  2016-12-20       Impact factor: 13.751

Review 4.  Strengths and Weaknesses of Pre-Clinical Models for Human Melanoma Treatment: Dawn of Dogs' Revolution for Immunotherapy.

Authors:  Giuseppina Barutello; Valeria Rolih; Maddalena Arigoni; Lidia Tarone; Laura Conti; Elena Quaglino; Paolo Buracco; Federica Cavallo; Federica Riccardo
Journal:  Int J Mol Sci       Date:  2018-03-10       Impact factor: 5.923

5.  Radiotherapy enhances natural killer cell cytotoxicity and localization in pre-clinical canine sarcomas and first-in-dog clinical trial.

Authors:  Robert J Canter; Steven K Grossenbacher; Jennifer A Foltz; Ian R Sturgill; Jiwon S Park; Jesus I Luna; Michael S Kent; William T N Culp; Mingyi Chen; Jaime F Modiano; Arta M Monjazeb; Dean A Lee; William J Murphy
Journal:  J Immunother Cancer       Date:  2017-12-19       Impact factor: 13.751

Review 6.  There and back again: Translating adoptive cell therapy to canine cancer and improving human treatment.

Authors:  Samuel A Brill; Douglas H Thamm
Journal:  Vet Comp Oncol       Date:  2021-07-18       Impact factor: 2.385

7.  Progress in Adaptive Immunotherapy for Cancer in Companion Animals: Success on the Path to a Cure.

Authors:  Katie L Anderson; Jaime F Modiano
Journal:  Vet Sci       Date:  2015-10-19

8.  NCR1 Expression Identifies Canine Natural Killer Cell Subsets with Phenotypic Similarity to Human Natural Killer Cells.

Authors:  Jennifer A Foltz; Srinivas S Somanchi; Yanwen Yang; Arianexys Aquino-Lopez; Erin E Bishop; Dean A Lee
Journal:  Front Immunol       Date:  2016-11-23       Impact factor: 7.561

Review 9.  Immunotherapy for Dogs: Running Behind Humans.

Authors:  Hans Klingemann
Journal:  Front Immunol       Date:  2018-02-05       Impact factor: 7.561

10.  Comparison of Phenotypic and Functional Characteristics Between Canine Non-B, Non-T Natural Killer Lymphocytes and CD3+CD5dimCD21- Cytotoxic Large Granular Lymphocytes.

Authors:  Soo-Hyeon Lee; Dong-Jun Shin; Yoseop Kim; Cheol-Jung Kim; Je-Jung Lee; Mee Sun Yoon; Tung Nguyen Thanh Uong; Dohyeon Yu; Ji-Youn Jung; Duck Cho; Bock-Gie Jung; Sang-Ki Kim; Guk-Hyun Suh
Journal:  Front Immunol       Date:  2018-04-27       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.